USP33 and lung carcinoma: We identified seven proteins (Amph, Dok3, Ddx17, Mbip, Rim2, Skap2, TACC3, and Usp33) that are predicted to be EGFR interaction partners and/or share interaction partners within the EGFR pathway, and three of these (Amph, Rim2, and TACC3) show increased expression levels in lung cancer (Fig. 2b and Supplementary Table 1).